FibroBiologics, Inc. Common Stock
USD0.83
+0.03 (+3.80%)
CEO
Peter O'Heeron
IPO Date
2024-02-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.80
Prev. Close
$0.79
Day Low
$0.80
Day High
$0.83
52W Low
$0.73
52W High
$14.68
Market Cap
$0.00B
Volume
0.03M
| -5.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -1315.6% | -139.5% | 1.39 | 1.00 | -57.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 128.2% | -106.2% | -1.88 | 0.37 | -184.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 122.6% | -338.0% | -1.01 | 0.27 | -597.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | -808.8 |
| -0.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -4622.4% | -66.1% | 56.90 | 0.78 | -1.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -541.6% | -33.5% | 12.53 | 0.93 | -1.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -211.3% | -43.5% | 3.03 | 1.14 | -1.7 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -113.3% | -18.8% | 3.86 | 1.12 | -5.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -18.3% | -4.8% | 0.57 | 1.23 | -51.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -37.6% | 10.1% | -0.77 | 0.64 | 36.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 219.0% | -74.2% | -0.55 | 0.64 | -10.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -775.5% | -82.2% | 1.39 | 1.00 | -23.8 |